Clinical Trial: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: End Stage Renal Disease on Dialysis
Study Type: INTERVENTIONAL
Official Title: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease
Brief Summary:
The main purpose of the study is to determine if empagliflozin can reduce peritoneal glucose absorption in patients with end stage renal diease (ESRD) on peritoneal dialysis.This is a randomized, placebo controlled, acute crossover study of empagliflozin in an anticipated 30 chronic PD patients, with an 8 week "pre post" open label extension in all 30 patients where they will receive empagliflozin daily.
Read more